Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial
Przemyslaw Kardas
Vasc Health Risk Manag. 2007 April; 3(2): 235–242.